- Home
- WHF vs ZYXI Comparison
WHF vs ZYXI Comparison
Compare WHF & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHF
- ZYXI
- Stock Information
- Founded
- WHF 2011
- ZYXI 1996
- Country
- WHF United States
- ZYXI United States
- Employees
- WHF N/A
- ZYXI N/A
- Industry
- WHF Finance Companies
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WHF Finance
- ZYXI Health Care
- Exchange
- WHF Nasdaq
- ZYXI Nasdaq
- Market Cap
- WHF 243.6M
- ZYXI 248.4M
- IPO Year
- WHF 2012
- ZYXI N/A
- Fundamental
- Price
- WHF $10.49
- ZYXI $8.11
- Analyst Decision
- WHF Hold
- ZYXI Strong Buy
- Analyst Count
- WHF 4
- ZYXI 2
- Target Price
- WHF $12.25
- ZYXI $14.00
- AVG Volume (30 Days)
- WHF 88.7K
- ZYXI 113.1K
- Earning Date
- WHF 11-07-2024
- ZYXI 10-24-2024
- Dividend Yield
- WHF 14.67%
- ZYXI N/A
- EPS Growth
- WHF N/A
- ZYXI N/A
- EPS
- WHF 0.45
- ZYXI 0.15
- Revenue
- WHF $97,441,000.00
- ZYXI $193,665,000.00
- Revenue This Year
- WHF N/A
- ZYXI $10.70
- Revenue Next Year
- WHF N/A
- ZYXI $19.78
- P/E Ratio
- WHF $23.44
- ZYXI $54.84
- Revenue Growth
- WHF N/A
- ZYXI 4.21
- 52 Week Low
- WHF $10.42
- ZYXI $7.15
- 52 Week High
- WHF $13.44
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- WHF 26.25
- ZYXI 47.10
- Support Level
- WHF $10.49
- ZYXI $7.70
- Resistance Level
- WHF $11.79
- ZYXI $9.33
- Average True Range (ATR)
- WHF 0.22
- ZYXI 0.41
- MACD
- WHF -0.07
- ZYXI -0.11
- Stochastic Oscillator
- WHF 5.11
- ZYXI 25.15
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.